Home
Company
Therapeutic Focus
Pipeline
UNI-494
Renazorb
Investors
Resources
Contact
All SEC Filings
Investors
Investors
Overview
News
Events & Presentations
IR Calendar
Presentations
Governance
Overview
Management Team
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Financial & Stock Info
Overview
Financial Results
Quote
Charts
Historical Data
Analyst Coverage
Resources
Overview
Contacts
FAQ
Email Alerts
Filing Type:
View All
10-K
10-Q
3
4
4/A
424B3
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
Date
Form
Description
PDF
XBRL
Pages
02/14/24
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
7
02/05/24
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
3
01/22/24
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
6
12/08/23
S-8
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Documents
expand_more
EX-5.1
EX-23.1
EX-FILING FEES
7
11/14/23
8-K
Current report filing
Documents
expand_more
EX-99.1
5
11/14/23
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
expand_more
EX-31.1
EX-31.2
EX-32.1
EX-32.2
29
10/23/23
8-K
Current report filing
Documents
expand_more
EX-99.1
4
09/25/23
8-K
Current report filing
2
09/07/23
4
Statement of changes in beneficial ownership of securities
1
09/07/23
4
Statement of changes in beneficial ownership of securities
1
rss_feed
Filing RSS
arrow_back
1
2
3
4
5
6
7
8
9
10
…19
arrow_forward
Email Alerts
Contacts
RSS News Feed